Digital Therapeutics Market Size & Share Report

1. The global digital therapeutics market is projected to grow from $8.28 billion in 2024 to $43.88 billion by 2032, with a compound annual growth rate (CAGR) of 23.2%. North America dominates with 47.42% market share as of 2023. Key aspects covered: 1.Market Definition:  Digital therapeutics (DTx) comprises software and devices that deliver evidence-based therapeutic interventions for disease prevention and management  Focuses on mental health, diabetes, respiratory and cardiovascular conditions 2.Growth Drivers:  Rising chronic disease prevalence  Increased smartphone and mobile health app adoption  Technological advancements in healthcare delivery  Growing demand from pharmaceutical companies and physicians 3.Market Segments:  By Type: Devices, Software & Services  By Application: Prevention (prediabetes, obesity) and Treatment (diabetes, respiratory care, mental health, cardiovascular)  By Sales Channel: B2B and B2C 4.Recent Developments:  October 2023: Better Therapeutics launched AspyreRx, first cognitive behavioral therapy app for type 2 diabetes  September 2022: Prosoma Digital Therapeutics partnered with EVERSANA for cancer patient mental health solutions 5.Key Market Players:  Pear Therapeutics (market leader in software solutions)  Omada Health  Welldoc  Fitbit Health Solutions  CANARY HEALTH Report- Fortune Business Insights - Digital Therapeutics Market Size, Share, Growth Report, 2032 https://www.fortunebusinessinsights.com/digital-therapeutics-market-103501